Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / GOSS - Cerus Inks FDA Contract And Other News: The Good Bad And Ugly Of Biopharma

GOSS - Cerus Inks FDA Contract And Other News: The Good Bad And Ugly Of Biopharma

Gossamer Bio Inc.
  • Cerus Corporation inks FDA contract for Pathogen Reduction technology.
  • Twist Biosciences strikes new deal for T Cell therapies.
  • Gossamer Bio announces disappointing data for Asthma and Chronic Rhinosinusitis trials.

For further details see:

Cerus Inks FDA Contract, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: Gossamer Bio Inc.
Stock Symbol: GOSS
Market: NYSE
Website: gossamerbio.com
Menu
GOSS GOSS Quote GOSS Short GOSS News GOSS Articles GOSS Message Board
Get GOSS Alerts

News, Short Squeeze, Breakout and More Instantly...